{"text": "# Abilify: A Comprehensive Review\n\nof its Mechanism and Side Effects\n\nAs of August 05, 2024, Abilify (aripiprazole) remains a widely prescribed\n\nantipsychotic medication for the treatment of schizophrenia, bipolar disorder,\n\nand irritability associated with autism. Developed by Otsuka Pharmaceutical\n\nCo., Ltd. (www.otsuka.co.jp), in collaboration with Eli Lilly and Company\n\n(www.lilly.com), Abilify has been approved for use in over 100 countries\n\nworldwide.", "embedding": []}